LogicBio Therapeutics, Inc. Stock-Based Compensation
LogicBio Therapeutics, Inc. reported Stock-Based Compensation of $2.49 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2022-11-14
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-09-30 was $798.00K, a 29.51% decline year-over-year.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-06-30 was $849.00K, a 14.84% decline year-over-year.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2022-03-31 was $846.00K, a 14.46% decline year-over-year.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for the quarter ending 2021-12-31 was $1.03M, a 64.42% increase year-over-year.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2021 was $4.14M, a 35.78% increase from fiscal 2020.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2020 was $3.05M, a 68.90% increase from fiscal 2019.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2019 was $1.81M, a 63.68% increase from fiscal 2018.
- LogicBio Therapeutics, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $1.10M, a 140.00% increase from fiscal 2017.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2022-09-30 | $798.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $1.65M derived: sum of 2 quarters · filed 2022-11-14 | $2.49M 10-Q · filed 2022-11-14 | $3.52M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-06-30 | $849.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.70M 10-Q · filed 2022-08-15 | $2.72M derived: sum of 3 quarters · filed 2022-08-15 | $3.85M derived: sum of 4 quarters · filed 2022-11-14 |
| 2022-03-31 | $846.00K 10-Q · filed 2022-05-16 | $1.87M derived: sum of 2 quarters · filed 2022-05-16 | $3.00M derived: sum of 3 quarters · filed 2022-11-14 | $4.00M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $2.16M derived: sum of 2 quarters · filed 2022-11-14 | $3.15M derived: sum of 3 quarters · filed 2022-11-14 | $4.14M 10-K · filed 2022-03-04 |
| 2021-09-30 | $1.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.13M derived: sum of 2 quarters · filed 2022-11-14 | $3.12M 10-Q · filed 2022-11-14 | $3.74M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $997.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $1.99M 10-Q · filed 2022-08-15 | $2.61M derived: sum of 3 quarters · filed 2022-08-15 | $3.46M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $989.00K 10-Q · filed 2022-05-16 | $1.61M derived: sum of 2 quarters · filed 2022-05-16 | $2.47M derived: sum of 3 quarters · filed 2022-05-16 | $3.24M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $624.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-04 | $1.48M derived: sum of 2 quarters · filed 2022-03-04 | $2.25M derived: sum of 3 quarters · filed 2022-03-04 | $3.05M 10-K · filed 2022-03-04 |
| 2020-09-30 | $854.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.62M derived: sum of 2 quarters · filed 2021-11-15 | $2.43M 10-Q · filed 2021-11-15 | $2.91M derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $1.57M 10-Q · filed 2021-08-09 | $2.05M derived: sum of 3 quarters · filed 2021-08-09 | $2.57M derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | $805.00K 10-Q · filed 2021-05-10 | $1.28M derived: sum of 2 quarters · filed 2021-05-10 | $1.80M derived: sum of 3 quarters · filed 2021-05-10 | $2.34M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-15 | $1.00M derived: sum of 2 quarters · filed 2021-03-15 | $1.53M derived: sum of 3 quarters · filed 2021-03-15 | $1.81M 10-K · filed 2021-03-15 |
| 2019-09-30 | $522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $1.05M derived: sum of 2 quarters · filed 2020-11-09 | $1.33M 10-Q · filed 2020-11-09 | $1.91M derived: sum of 4 quarters · filed 2020-11-09 |
| 2019-06-30 | $531.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $807.00K 10-Q · filed 2020-08-10 | $1.39M derived: sum of 3 quarters · filed 2020-08-10 | $1.68M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $276.00K 10-Q · filed 2020-05-11 | $860.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.15M derived: sum of 3 quarters · filed 2020-05-11 | $1.29M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $584.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $871.00K derived: sum of 2 quarters · filed 2020-03-16 | $1.02M derived: sum of 3 quarters · filed 2020-03-16 | $1.10M 10-K · filed 2020-03-16 |
| 2018-09-30 | $287.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $432.00K derived: sum of 2 quarters · filed 2019-11-12 | $520.00K 10-Q · filed 2019-11-12 | $831.00K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $145.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-13 | $233.00K 10-Q · filed 2019-08-13 | $544.00K derived: sum of 3 quarters · filed 2019-08-13 | |
| 2018-03-31 | $88.00K 10-Q · filed 2019-05-14 | $399.00K derived: sum of 2 quarters · filed 2019-05-14 | ||
| 2017-12-31 | $311.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $460.00K 10-K · filed 2019-04-01 | ||
| 2017-09-30 | $149.00K 10-Q · filed 2018-12-03 |